Results
Type
Country of origin
Qualifications

Droxidopa bulk suppliers | with CEP, CoA, DMF, FDA, GMP, WC | send inquiries for free

Here you will find a list of producers, manufacturers and traders of Droxidopa. You can sort by certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
Dasami Labs Private Limited

MOQ: 15 kg
Type: Producer
Origin: India
India
Lupin


Type: Producer
Origin: India
India
JINLAN Pharm-Drugs Technology Co., Ltd.

MOQ: 1 g
Type: Producer
Origin: China
China
MSN Life Sciences


Type: Producer
Origin: India
India
EstechPharma


Type: Producer
Origin: South Korea
South Korea
Quimica Sintetica


Type: Producer
Origin: Spain
Spain
Clarochem


Type: Producer
Origin: Ireland
Ireland
Apicore


Type: Producer
Origin: United States
United States
Chongqing Shenghuaxi


Type: Producer
Origin: China
China

Looking for Droxidopa 23651-95-8?

API | Excipient name:
Droxidopa 
Synonyms:
L-Dihydroxyphenylserine, DOPS, L-DOPS, L-threo-dihydroxyphenylserine  
Cas Number:
23651-95-8 
DrugBank number:
DB06262 
Unique Ingredient Identifier:
J7A92W69L7

About Droxidopa

Here you will find more information about Droxidopa. Droxidopa is a precursor of noradrenaline that is used in the treatment of Parkinsonism. It is approved for use in Japan and is currently in trials in the USA The racaemic form (dl-threo-3-dihydroxyphenylserine) has also been used, and has been investigated in the treatment of orthostatic hypotension. There is a deficit of noradrenaline as well as of dopamine in Parkinson's disease and it has been proposed that this underlies the sudden transient freezing seen usually in advanced disease.

Though L-DOPS has been used in Japan and Southeast Asia already for some time, it is also currently in clinical trials at the phase III point in the United States (USA), Canada, Australia, and throughout Europe. Provided L-DOPS successfully completes clinical trials, it could be approved for the treatment of neurogenic orthostatic hypotension (NOH) as early as 2011. Additionally, phase II clinical trials for intradialytic hypotension are also underway. Chelsea Therapeutics obtained orphan drug status (ODS) for L-DOPS in the USA for NOH, and that of which associated with Parkinson's disease , pure autonomic failure, and multiple system atrophy, and is the pharmaceutical company developing it in that country.

Check who is selling Droxidopa in the overview above.

Droxidopa manufacturers | traders | suppliers
We have 9 companies offering Droxidopa from 4 different countries.

Get in contact with the supplier of your choice:

  • JINLAN Pharm-Drugs Technology Co., Ltd. from China
  • Lupin from India
  • Dasami Labs Private Limited from India
  • MSN Life Sciences from India
  • Quimica Sintetica from Spain
  • Clarochem from Ireland
  • Apicore from United States
  • EstechPharma from South Korea
  • Chongqing Shenghuaxi from China

Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.

You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.